`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF DELAWARE
`
`GENENTECH, INC. and CITY OF HOPE,
`
`Plaintiffs and Counterclaim
`Defendants,
`
`v.
`
`AMGEN INC.,
`
`Defendant and Counterclaim
`Plaintiff.
`
`GENENTECH, INC. and CITY OF HOPE,
`
`Plaintiffs and Counterclaim
`Defendants,
`
`Civ. No. 18-924-CFC
`
`v.
`
`Civ. No. 18-1363-CFC
`
`SAMSUNG BIOEPSIS CO., LTD.,
`
`Defendant and Counterclaim
`Plaintiff.
`
`ORDER
`
`For the reasons stated in the accompanying Memorandum Opinion, IT IS
`
`HEREBY ORDERED, that the disputed claim terms are construed as follows:
`
`
`
`Case 1:18-cv-01363-CFC Document 157 Filed 06/14/19 Page 2 of 3 PageID #: 14860
`
`Claim Term
`
`Court's Construction
`
`"a method for increasing likelihood
`of effectiveness of breast cancer
`treatment with humanized anti-ErbB2
`antibody huMAb4D5-8"
`('834 patent)
`
`A method of treatment of patients who
`have a greater likelihood of responding
`to treatment by administering humanized
`anti-ErbB2 antibody huMAb4D5-8. The
`preamble is limiting.
`
`"pre-harvest [ culture fluid]"
`('869 patent)
`
`No construction needed. Plain and
`ordinary meaning.
`
`"wherein the patient's cancer cells
`express HER2 at a O or 1 + level by
`immunohistochemistry"
`('066 patent)
`
`Wherein the patient's cancer cells have
`been found to express HER2 at a O or 1 +
`level by any immunohistochemistry test
`
`"a glutamine-free production culture Culture medium used in the production
`medium"
`phase that is not formulated or
`supplemented with glutamine
`('983 patent)
`
`"wherein said citric acid or citrate is During the cultivation of the cells the
`maintained at a concentration of
`citric acid or citrate is maintained at a
`about 1 to 50 mmol/L during
`concentration of between approximately
`cultivation" and "is not bound in a
`I and approximately 50 mmol/1 and is
`chelate complex with iron or another
`not bound in a chelate complex with iron
`transition metal ion"
`or another transition metal ion
`(' 660 patent)
`
`IT IS HEREBY FURTHER ORDERED, for the reasons stated in the
`
`Memorandum Opinion, that the parties shall submit a joint status report by June 24,
`
`2019 setting forth their proposed process and timing for deciding whether the claim
`
`2
`
`
`
`Case 1:18-cv-01363-CFC Document 157 Filed 06/14/19 Page 3 of 3 PageID #: 14861
`
`term "following fermentation" can be construed by resort to extrinsic evidence or is
`
`invalid for indefiniteness.
`
`Dated: June 14, 2019
`
`UNITED STATES Dis
`
`3
`
`